Harrow HROW
NASDAQ HROW
$28.46 +0.78 (+2.82%)
As of: Oct 20, 2026 · 1:36 PM EDT

Harrow (HROW) Shares Repurchased (2013)

Updated

Analysis

Harrow (HROW) Shares Repurchased (2013) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Repurchased (Qtr)
1 Eli Lilly 1,156.72 Bn 1,125.31 Bn 19.71 Bn 1.60 Bn
2 Johnson & Johnson 623.54 Bn 542.07 Bn 17.26 Bn 221.00 Mn
3 AbbVie 513.03 Bn 486.14 Bn 12.70 Bn 9.00 Mn
4 Merck 365.42 Bn 319.80 Bn 12.21 Bn 757.00 Mn
5 Novartis Ag 297.47 Bn 261.46 Bn 11.24 Bn 1.20 Bn
6 Astrazeneca 261.54 Bn 235.23 Bn 12.86 Bn -
7 Amgen 235.13 Bn 190.53 Bn 7.24 Bn -
8 Gilead Sciences 193.32 Bn 167.51 Bn 6.22 Bn 355.00 Mn
9 Pfizer 171.63 Bn 118.28 Bn 10.94 Bn -
10 Harrow 1.06 Bn 736.50 Mn 50.36 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2013 -1.00
Mar 31, 2013 192.00
API Access

Harrow Shares Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-repurchased&ticker=HROW&period=max&api_key=YOUR_API_KEY